Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Advances in Sphingosine-1-phosphate (S1P) Therapeutics to Improve Outcomes in Patients with Inflammatory Bowel Disease

Program Overview

This CME activity will highlight advances in sphinogosine-1-phosphate (S1P) therapeutics to improve outcomes in patients with inflammatory bowel disease. The expert faculty, led by Dr. William Sandborn, will discuss how sphingosine-1-phosphate (S1P) receptor modulators are utilized as a therapeutic target to reduce inflammation in patients with inflammatory bowel disease (IBD). Recent and emerging clinical trial data on the ...
View Course
Clinical Trial Analysis of BRAF and Anti-PD-1 Targeted Therapeutic Options for Colorectal Cancer

Program Overview

In this module, Ryan B. Corcoran, MD PhD, along with Scott Kopetz, MD, PhD, course chair, will highlight current clinical trial data for BRAF and Anti-PD-1 targeted therapeutic options in the colorectal cancer treatment landscape. The expert faculty will provide an in-depth review of novel studies by analyzing study populations, methods and results, as well as providing key ...
View Course
Targeted Anti-PD-1-based Therapies and Adverse Event Mitigation to Improve Outcomes in Patients with CRC

Program Overview

In this module, Michael J. Overman, MD, along with Scott Kopetz, MD, PhD, course chair, will review clinical trial data of approved and emerging targeted Anti-PD-1-based therapies for the treatment of patients with colorectal cancer, debating the clinical relevance of each in a discussion-based format. The toxicity spectrum of immune-related adverse events will be covered, along with kinetics ...
View Course
Colorectal Cancer Update: Prevalence, Screening, Biomarker and Genomic Testing, and Therapeutic Targets

Program Overview

In this module, Jonathan Loree, MD, MS, along with Scott Kopetz, MD, PhD, course chair, will first provide a brief overview of the history and prevalence of colorectal cancer, as well as best practices for screening. Following, the expert faculty will review the role of clinically relevant biomarkers in metastatic colorectal cancer. Strategies for detecting and managing various ...
View Course

Upcoming Events

2021 Joint Pre-ECTRIMS Online Workshop

October 11th – 12th, 2021

CME/CE Symposium at the Congress of Clinical Rheumatology West Meeting

September 19th, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022